BetterScholar BetterScholar

G. Y. Veroli

Bioinform., Nature Communications, Scientific Reports, Cardiovascular Electrophysiology, PLoS Comput. Biol.
10
Role
Title
Level Year L/R
🦁 Combenefit: an interactive platform for the analysis and visualization of drug combinations
7 auth. G. Y. Veroli, Chiara Fornari, Dennis Wang, S. Mollard, J. L. Bramhall, F. Richards, ... D. Jodrell 		9 2016
9
🦁
🐜 Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
26 auth. M. Menden, Dennis Wang, M. Mason, B. Szalai, K. Bulusu, Y. Guan, Thomas Yu, Jaewoo Kang, Minji Jeon, R. Wolfinger, Tin Nguyen, M. Zaslavskiy, I. S. Jang, Z. Ghazoui, M. Ahsen, ... Robert M. Vogel, E. C. Neto, Thea C. Norman, E. Tang, M. Garnett, G. Y. Veroli, S. Fawell, G. Stolovitzky, J. Guinney, J. Dry, J. Saez-Rodriguez 		7 2019
7
🐜
🦁 An automated fitting procedure and software for dose-response curves with multiphasic features
8 auth. G. Y. Veroli, Chiara Fornari, Ian Goldlust, G. Mills, Siang-Boon Koh, J. L. Bramhall, ... F. Richards, D. Jodrell 		7 2015
7
🦁
🦁 hERG Inhibitors with Similar Potency But Different Binding Kinetics Do Not Pose the Same Proarrhythmic Risk: Implications for Drug Safety Assessment
G. Y. Veroli, M. Davies, Henggui Zhang, N. Abi-Gerges, M. Boyett 		6 2014
6
🦁
🐜 Community assessment of cancer drug combination screens identifies strategies for synergy prediction
27 auth. Michael P. Menden, Dennis Wang, Y. Guan, M. Mason, B. Szalai, K. Bulusu, Thomas Yu, Jaewoo Kang, Minji Jeon, R. Wolfinger, Tin Nguyen, M. Zaslavskiy, AstraZeneca-Sanger Drug Combination Dream Consorti, I. S. Jang, Z. Ghazoui, ... M. Ahsen, Robert M. Vogel, E. C. Neto, Thea C. Norman, E. Tang, M. Garnett, G. Y. Veroli, S. Fawell, G. Stolovitzky, J. Guinney, J. Dry, J. Saez-Rodriguez 		4 2017
4
🐜
🐬 Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy
R. Jackson, G. Y. Veroli, Siang-Boon Koh, Ian Goldlust, F. Richards, D. Jodrell 		3 2017
3
🐬
🦁 Dynamics of drug binding to the hERG channel: An in silico cardiac action potential model for early safety assessment
7 auth. G. Y. Veroli, M. Davies, C. Pollard, J. Valentin, Henggui Zhang, M. Boyett, ... N. A. Gerges 		0 2011
0
🦁
🐜 The AstraZeneca-Sanger DREAM synergy prediction challenge
11 auth. Michael P. Menden, Dennis Wang, Elias Chaibub-Neto, J. Sock, Z. Ghazoui, Thomas Yu, ... G. Y. Veroli, G. Stolovitzky, J. Guinney, J. Dry, J. Saez-Rodriguez 		0 2015
0
🐜
🦁 Abstract 2540: A new mathematical model and software, to enable improved quantification and interpretation of combinatorial drug effects
G. Y. Veroli, D. Jodrell, F. Richards, Ian Goldlust 		0 2015
0
🦁